HTLV-1 Task Force Publishes Open Letter To WHO Proposing More Action To Prevent Virus
The Lancet: Time to eradicate HTLV-1: an open letter to WHO
Fabiola Martin, Yutaka Tagaya, Robert Gallo, all members of the Global Virus Network’s HTLV-1 Task Force
“Human T-cell leukemia virus 1 (HTLV-1) is the most potent carcinogenic oncovirus and potentially the most oncogenic risk factor including chemical carcinogens. … HTLV-1 remains a strong threat to individual and community health, and even more so to global health because of the accelerated rate of human migration in recent times. … We feel strongly that research on the pathogenesis and treatment of this virus needs to be encouraged not only for the sake of HTLV-1 positive patients but also as a model for other human diseases including virus-related cancer. … We have published an open letter to WHO, proposing a WHO HTLV-1 vision for the prevention of HTLV-1 transmission, signed by more than 50 individuals and organizations. The letter states, ‘[I]t is time to do more for HTLV-1, including five intervention strategies to reduce the incidence of HTLV-1 infection,’ and we encourage you to read it online” (5/12).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.